Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Here's Where Abbott Laboratories Is Finding Its Growth
Motley Fool
Wednesday, March 28, 2012 - 4:05pm
tags:
Abbott Laboratories
Bristol-Myers in partnership for Alzheimer's test
Yahoo/AP
Wednesday, March 28, 2012 - 4:04pm
tags:
Alzheimer's disease, Bristol-Myers Squibb, Meso Scale Discovery
FDA OKs New Anemia Med That Challenges Amgen
Pharmalot
Wednesday, March 28, 2012 - 11:27am
tags:
FDA, Amgen, anemia, Epogen, Omontys, Affymax, Aranesp
Future Trends In RNAi Drug Delivery
Seeking Alpha
Wednesday, March 28, 2012 - 11:20am
tags:
RNAi, Alnylam
Is a Pfizer Breakup in the Cards? How Much Would it be Worth?
Barron's
Wednesday, March 28, 2012 - 11:06am
tags:
Pfizer
Allergan Botox works in overactive bladder studies
Reuters
Wednesday, March 28, 2012 - 11:06am
tags:
Botox, Allergan, overactive bladder
Amilyn Soars on News of Spurned Bristol-Myers Bid
Barron's
Wednesday, March 28, 2012 - 10:27am
tags:
Amylin, Bristol-Myers Squibb, M&A
Neurocrine's News Not As Bad As The Market Thinks
Seeking Alpha
Wednesday, March 28, 2012 - 10:20am
tags:
Neurocrine, Abbott Laboratories, NBI-98854, tardive dyskinesia
Large Market Opportunity Emerges For Oculus Technology
Seeking Alpha
Wednesday, March 28, 2012 - 10:19am
tags:
Oculus, GSK, JNJ, Novartis, Sanofi, Vivus
Pharma's 4 Biggest Losers
Seeking Alpha
Wednesday, March 28, 2012 - 10:17am
tags:
Abbott Laboratories, Watson, Mark, 3SBio
Cardiome Pharma 4Q loss shrinks on lower costs
Yahoo/AP
Wednesday, March 28, 2012 - 10:15am
tags:
Cardiome, earnings
Merck says key Vytorin study cleared to continue
Reuters
Wednesday, March 28, 2012 - 10:12am
tags:
Merck, Vytorin
Bristol-Myers offers $3.5 billion for Amylin-Bloomberg
Reuters
Wednesday, March 28, 2012 - 10:12am
tags:
Amylin, Bristol-Myers Squibb, M&A
Biogen executive team rakes in millions from its 2011 successes
Fierce Biotech
Tuesday, March 27, 2012 - 10:40am
tags:
Biogen Idec, George Scangos
Stock Watch: SIGA Opens The Week With A Bang
Seeking Alpha
Tuesday, March 27, 2012 - 10:39am
tags:
SIGA technologies, PharmAthene
Drug companies watching India’s drug patent case
Globe and Mail, Canada
Tuesday, March 27, 2012 - 10:09am
tags:
patents, India, Novartis
Antidepressants give drugmakers the blues
Reuters
Tuesday, March 27, 2012 - 10:07am
tags:
antidepressants, Targacept, AstraZeneca, GSK
Targacept reports mixed data from two trials
Reuters
Tuesday, March 27, 2012 - 10:06am
tags:
Targacept, diabetes, asthma, TC-6987
Dynavax reports final Phase 3 data for HEPLISAV
Yahoo/Fly on the Wall
Tuesday, March 27, 2012 - 10:05am
tags:
Heplisav, Dynavax, chronic kidney disease
Why the Street Should Love Endo Pharmaceuticals' Earnings
Motley Fool
Tuesday, March 27, 2012 - 10:03am
tags:
earnings, Endo

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.